Clin2
NCT07842900Possibly a fitNot yet recruiting

Melatonin as add-on treatment for adult eczema

Atopic Dermatitis

Treatments studied

Part of Brain & nervous system, Genetic & congenital, Immune system & allergy, Mental health, Skin clinical trials.

This trial tests whether taking a melatonin supplement (a hormone that helps with sleep) alongside standard eczema treatment can improve symptoms in adults with atopic dermatitis. It may help reduce itching and skin inflammation, and improve sleep quality.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
130 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older and have been diagnosed with atopic dermatitis (often called eczema).
  • You have itchy skin and typical eczema patches, especially in body folds, and a history of eczema, asthma, or allergies in yourself or your family.
  • You are not currently taking supplements like vitamin C, vitamin E, zinc, iron, or folic acid, and you have not taken them in the last 3 months.
  • You have not used sleep or antidepressant medications in the past 4 weeks.
  • You do not have serious health issues such as a severe infection, HIV/AIDS, diabetes, a bleeding disorder, or a known allergy to melatonin.
  • You are not pregnant or breastfeeding, and you do not have a neurological or psychiatric condition that causes sleep problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05042258Recruiting· Phase 4
Dupilumab to improve sleep and itch in children with eczema

This trial studies whether dupilumab can improve daily body clock (circadian function), sleep, and itching in children with moderate-to-severe eczema that isn’t well controlled by creams. It may help kids who are having significant sleep trouble and ongoing itch.

Chicago, Illinois
NCT06487000Not yet recruiting· Phase 2
Oral medication study for moderate to severe eczema

This study tests an oral medication (EC-18) for moderate to severe atopic dermatitis (eczema) to see if it can improve symptoms like itching and skin rash. It may be an option for people whose eczema is not controlled by topical treatments.

NCT05575882Recruiting
Skin cream trial to prevent relapses in very dry eczema skin

This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.

Ciudad Autónoma de Buenos Aire, Ciudad Autónoma de Buenos Aire
NCT06850311Recruiting· Phase 2/Phase 3
Herbal ointment for mild to severe eczema

This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.

New Taipei City
NCT06547372Recruiting
Dietary changes for eczema relief

This study tests whether a specific diet can help manage mild to moderate eczema. It involves eating whole foods provided by the researchers for a set period and tracking your skin health.

Singapore, Singapore
NCT05790330Recruiting
Study brain–skin links in teenagers with eczema

This study looks at how eczema may be connected to the brain and sleep, using questionnaires and MRI scans. It may help researchers understand what drives symptoms and how treatments could be improved.

London

Hear when a new Atopic Dermatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.